#Ireland #Dublin #biotechnology #Jazz Pharmaceuticals #Global Healthcare Conference

Jazz Pharmaceuticals to Participate in Citi's 2025 Global Healthcare Conference

On November 18, 2025, Jazz Pharmaceuticals plc (Nasdaq: JAZZ) announced its intent to participate in Citi's influential 2025 Global Healthcare Conference. This event is a significant platform for leading companies in the healthcare sector to share insights and discuss their latest innovations. Jazz Pharmaceuticals will engage in a fireside chat scheduled for December 2, 2025, beginning at 6:45 AM PST / 9:45 AM EST / 2:45 PM GMT.

The discussion will be accessible through an audio webcast, which will be hosted on the Investor Relations section of Jazz Pharmaceuticals' official website. Following the live event, a recorded replay will be made available for 30 days, allowing a broader audience to gain insights from the company’s discourse and initiatives. This approach underlines Jazz’s commitment to transparency and investor engagement.

About Jazz Pharmaceuticals

Founded with the mission of transforming the lives of patients through innovative medicines, Jazz Pharmaceuticals operates as a global biopharmaceutical company headquartered in Dublin, Ireland. The company dedicates significant resources to developing therapies for serious conditions where options are often limited. Its portfolio includes market-leading treatments for sleep disorders and epilepsy, as well as a rising selection of cancer medications, emphasizing their focus on serious diseases.

Jazz's strategy intertwines patient care with scientific advancement, fostering an environment for continuous progress in research and development. By prioritizing innovative therapies, the company sets the bar high for standards in oncology and neuroscience, fields where breakthroughs can dramatically alter patient outcomes.

The company prides itself on a patient-first ethos, ensuring that every decision made at Jazz Pharmaceuticals ultimately aims to improve the lives of those they serve. The significance of their work is echoed in their commitment to addressing unmet medical needs worldwide.

Conference Details & Investor Information

The upcoming participation at Citi's Global Healthcare Conference is not only an opportunity for Jazz Pharmaceuticals to present their current initiatives but also to foster relationships with potential investors and stakeholders in the healthcare space. Interviews and discussions in such forums expose decision-makers to innovative solutions and ongoing research efforts.

For those interested in tuning into the live discussion or accessing the replay, they can visit Jazz Pharmaceuticals' Investor Relations page at investor.jazzpharma.com/investors/events-presentations.

Through events like these, Jazz Pharmaceuticals continues to showcase their pioneering spirit, dedication to patient care, and alignment with investor interests in a rapidly evolving biopharma landscape. The dialogue and exchanges generated through these platforms are pivotal in maintaining transparency and engagement within the biopharmaceutical community, ultimately benefiting patients and stakeholders alike.

Jazz Pharmaceuticals remains committed to driving advancements in healthcare in every challenge they undertake, contributing to a vital field that impacts millions globally. For further information regarding Jazz Pharmaceuticals, please explore their website at www.jazzpharmaceuticals.com.